Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer

Immune checkpoint inhibitor (ICI)-based immunotherapy in triple negative breast cancer (TNBC) is achieving limited therapeutic results, requiring the development of more potent strategies. Combination of ICI with vaccination strategies would enhance antitumor immunity and response rates to ICI in pa...

Descripció completa

Dades bibliogràfiques

Autors principals:	Belén Aparicio, David Repáraz, Marta Ruiz, Diana Llopiz, Leyre Silva, Enric Vercher, Patrick Theunissen, Ibon Tamayo, Cristian Smerdou, Ana Igea, Marta Santisteban, Cristina Gónzalez-Deza, Juan J. Lasarte, Sandra Hervás-Stubbs, Pablo Sarobe
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2022-11-01
Col·lecció:	Frontiers in Immunology
Matèries:	triple negative breast cancer neoantigens immunogenicity polyepitopic vaccines HLA-A*02:01 epitopes
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.985886/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!